Matrix stiffness modulates ILK-mediated YAP activation to control the drug resistance of breast cancer cells

基质硬度调节 ILK 介导的 YAP 活化以控制乳腺癌细胞的耐药性

阅读:5
作者:Xiang Qin, Xiaoying Lv, Ping Li, Rui Yang, Qiong Xia, Yu Chen, Yueting Peng, Li Li, Shun Li, Tingting Li, Ying Jiang, Hong Yang, Chunhui Wu, Chuan Zheng, Jie Zhu, Fengming You, Heng Wang, Jiong Chen, Yiyao Liu

Abstract

One of the hallmarks of cancer progression is strong drug resistance during clinical treatments. The tumor microenvironment is closely associated with multidrug resistance, the optimization of tumor microenvironments may have a strong therapeutic effect. In this study, we configured polyacrylamide hydrogels of varying stiffness [low (10 kPa), intermediate (38 kPa) and high (57 kPa)] to simulate tissue physical matrix stiffness across different stages of breast cancer. After treatment with doxorubicin, cell survival rates on intermediate stiffness substrate are significantly higher. We find that high expression of ILK and YAP reduces the survival rates of breast cancer patients. Drug resistance is closely associated with the inactivation of the hippo pathway protein Merlin/MST/LATS and the activation of YAP. These results not only highlight the understanding of drug resistance mechanisms but also serve as a new basis for developing breast cancer treatment delivery systems.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。